Search Results

Overview of Endovascular Management of Traumatic Carotid Lesions

Determining appropriate intervention based on lesion severity and patient characteristics.

By Ricardo Yamada, MD; Craig Miller; Marcelo Guimaraes, MD; and Claudio Schönholz, MD

Access Strategy and Improvement

By Barry T. Katzen, MD, Chief Medical Editor

The Power-Pulse Spray Technique

A novel simultaneous combination therapy allows rapid revascularization in critical limb ischemia.

By DAVID E. ALLIE, MD; CHRIS J. HEBERT, RT, RCIS; MOHAMED H. KHAN, MD; AND CRAIG M. WALKER, MD

Pressure-Sensing Guidewire Analysis in RAS

Adapting this coronary-based technology to optimize “functional” renal artery revascularization could have significant clinical implications.

By David E. Allie, MD; Chris J. Hebert, RT, RCIS; and Craig M. Walker, MD

Ask the Experts: What Will Dominate the Next Era in SFA Therapy?

Experts discuss the current era of drug-eluting technologies and what might come next.

With Koen Deloose, MD; Craig Walker, MD; and Ramon L. Varcoe, MBBS, MS, FRACS, PhD

Plaque Excision for Treatment of Restenosis

Use of a novel device for recurrent stenosis in the superficial femoral artery.

By Barry S. Weinstock, MD

Challenges and Opportunities for the Next Generation of PAD Specialists

A discussion on training, subspecialization, practicing in an OBL versus a hospital, finding a mentor, and more.

With Jun Li, MD; Lorenzo Patrone, MD; and Michael C. Siah, MD

Popliteal Artery Aneurysms

There is an increasing role of endovascular therapy for the management of popliteal artery aneurysmal disease.

By Li Sheng Kong, MD; Karthikeshwar Kasirajan, MD; and Ross Milner, MD

Endograft Treatment in the SFA

Current SFA stent graft technology has overcome early shortcomings and carries the potential to become the standard of care in selected patients.

By Mark W. Mewissen, MD

Acute Arterial Thrombosis Prevention and Management During SFA and Popliteal Interventions

Acute limb ischemia carries a serious short-term risk, and knowing the ins and outs of treatment options is crucial for lowering the rates of morbidity, mortality, and amputation.

By George L. Adams, MD, MHS, and O Jesse Mendes, BA